Bannon, ML and Roth, RH (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev. 35: 53-68.

Bashki, VP, Swerdlow, NR and Geyer, MA (1994) Clozapine antagonises phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther. 271: 787-794.

Bristow, LJ, Kramer, MS, Kulagowski, J, Patel, S, Ragan, CI and Seabrook, GR (1997) Schizophrenia and L745,870, a novel dopamine D4 receptor antagonist. Trends Pharmacol. Sci. 18: 186-188.

Busatto, GF and Kerwin, RW (1997) Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. J. Psychopharm. 11: 3-12.

Chiodi, LA and Bunney, BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopamine neurones. J. Neurosci. 3: 1607-1619.

Crow, TJ (1985) The two syndrome concept: origins and current status. Schizophr. Bull. 11: 471-486.

Dalley, JW and Webster, RA (1993) Dopamine-like effects of clozapine on spontaneously active neurons in the rat prefrontal cortex. J. Psychopharm. 7: A7.

Farde, L (1996) The advantage of using positron emission tomography in drug research. Trends Neurosci. 19: 211-214.

Farde, L, Wiesel, FA, Nordstrom, AL and Sedvall, G (1989) Dj and D2 dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99 (Suppl): 528-531.

Geyer, MA, Swerdlow, NR, Mansbach, RS and Braff, DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull. 25: 485-498.

Grace, AA, Bunney, BS, Moore, H and Todd, CL (1997) Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci. 20: 31-37.

Ishimaru, M, Kurumaji, A and Toru, M (1994) Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis. Biol. Psychiat. 35: 84-95.

Kerwin, R (1992) A history of frontal and temporal lobe aspects of the neuropharmacology of schizophrenia. J. Psychopharm. 6: 230-240.

Knoble, MB and Weinberger, DR (1997) Dopamine, the prefrontal cortex and schizophrenia. J. Psychopharm. 21: 123-131.

Lidow, MS, Williams, GV and Goldman-Rakic, PS (1998) The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol. Sci. 19: 136-140.

Nutt, DJ, Lalies, MD, Lione, LA and Hudson, AL (1997) Noradrenergic mechanisms in the prefrontal cortex. J. Psychopharm. 11: 163-168.

Pilowsky, LS, Costa, DC and Eli, PJ (1992) Clozapine single photon emission tomography and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet 340: 199-202.

Pycock, CJ, Kerwin, RW and Carter, CJ (1980) Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286: 74-77.

Reynolds, GP (1995) Neurotransmitter systems in schizophrenia. Int. Rev. Neurobiol. 38: 305-359.

Reynolds, GP (1997) What is an atypical antipsychotic? J. Psychopharm. 11: 195-199.

Robertson, GS, Mastumura, H and Fibiger, HC (1994) Induction patterns of Fos-like immuno-reactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 271: 1058-1061 (see also Neuropsychopharmacology 14: 105-110).

Seeman, P (1980) Brain dopamine receptors. Pharmacol. Rev. 32: 229-313.

Seeman, P (1990) Atypical neuroleptics: role of multiple receptors, endogenous dopamine and receptor linkage. Act. Psychiatr. Scand. 82 (Suppl. 358): 14-20.

Seeman, P (1992) Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7: 261-284.

Seeman, P, Guan, HC and Van Tol, HHM (1993) Dopamine D4 receptors elevated in schizophrenia. Nature 365: 441-445.

Seeman, P and Van Tol, HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15: 61-72.

Sokoloff, P and Schwartz, JC (1995) Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16: 270-275.

Strange, PG (1994) Dopamine D4 receptors: curiouser and curiouser. Trends Pharmacol. Sci. 15: 317-319.

Weinberger, DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiat. 44: 660-669.

Neurotransmitters, Drugs and Brain Function.

Edited by Roy Webster Copyright © 2001 John Wiley & Sons Ltd ISBN: Hardback 0-471-97819-1 Paperback 0-471-98586-4 Electronic 0-470-84657-7

Was this article helpful?

0 0

Post a comment